 "Drug firm Pfizer Q3 net profit surges 40% to Rs 872 mn on lower expenses")
The company had posted a net profit of Rs 623 million during the same period of the previous fiscal, Pfizer said in a regulatory filing.
Revenue from operations for the quarter under review stood at Rs 4.565 billion as compared to Rs 5.102 billion in the same period of the last year.
Also Read
It said net profit after tax (including other comprehensive income) for nine months ended December 31, 2017 was Rs 2.549 billion as against Rs 2.676 billion in the year-ago period.
The company's stock closed 4.30 per cent up at Rs 2,201.55 apiece on BSE on Wednesday.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%